Ozone Therapy (Autohemotherapy)

Ozone autohemotherapy (große Eigenblutbehandlung) withdraws a small volume of the patient's blood, enriches it with medical-grade ozone and oxygen, and reinfuses it intravenously. The treatment is used in Germany's integrative medicine sector to support immune regulation, improve cellular oxygenation, reduce chronic inflammation and promote circulation. Wellsana Berlin performs the procedure under medical supervision in a clinical setting, with protocols adapted to individual health goals.

Ozone therapy — specifically major autohemotherapy (große Eigenblutbehandlung) — is one of the established integrative treatments offered at German longevity clinics. The procedure draws a measured volume of blood from the patient, exposes it to a precise concentration of medical-grade ozone and oxygen within a closed sterile system, and reinfuses the treated blood intravenously. The ozonated blood is thought to stimulate antioxidant enzyme systems, improve red blood cell flexibility and oxygen delivery, modulate immune activity and reduce oxidative stress — effects that have made the treatment popular in Germany's evidence-informed private medicine sector, where it is used for immune support, post-viral fatigue, chronic inflammation, circulatory conditions and general longevity protocols. Ozone therapy is a self-pay treatment in Germany and is not covered by statutory health insurance, which means it is delivered at private practices and longevity clinics such as Wellsana Berlin. Germany has a longer tradition of medical ozone use than many other countries, with standardised protocols established by the German Medical Society for Ozone Therapy (Deutsche Ärztegesellschaft für Ozontherapie, DÄGfO), and practitioners are typically trained in these guidelines. At Wellsana Berlin Longevity, ozone autohemotherapy is offered as a standalone session or as part of a wider longevity protocol that may include IV infusions and diagnostics. Courses of 5–10 sessions are common for patients addressing specific chronic conditions; single sessions are available for those exploring the treatment. All sessions are performed under medical supervision in a clinical environment. Patients with contraindications — including active hyperthyroidism, glucose-6-phosphate dehydrogenase deficiency or certain clotting disorders — are screened at consultation before treatment begins.